55 Institutional Partners names Kogan chief investment scientist

Investment science and technology firm 55 Institutional Partners has named Dr. Leonid Kogan chief investment scientist.

Dr. Kogan, who was a firm research partner and leader of its proprietary tax optimization technology, will now lead 55 Institutional Partners’ research team and the development of its science and technology capabilities.

Dr. Kogan is a research associate at the National Bureau of Economic Research and the Nippon Telegraph and Telephone professor of management and professor of finance at the MIT Sloan School of Management. HIs research focuses on capital markets and has appeared in several prominent journals. It has won him awards including the Cromwell Memorial Prize, Whitebox Advisors Award and the Amundi Smith Breeden Prize. Dr. Kogan earned a Master’s degree from Moscow State University and PH.Ds from Cornell and MIT.

Dr. Leonid Kogan

“Leonid was instrumental in developing the company’s current investment capabilities, including our next generation technology that makes tax optimization more accessible, easier to implement and more effective than traditional methods in the marketplace,” 55 Institutional Partners CEO Paul Gamble said. “We are honoured to have him take on the overall leadership of our investment research team and further the development of our investment platform to benefit our clients and deliver better outcomes for investors.”

“We are honoured to have him take on the overall leadership of our investment research team and further the development of our investment platform to benefit our clients and deliver better outcomes for investors.”

“We are delighted to take Leonid’s involvement in the firm to the next level and excited to have one of the world’s best thinkers in investments help our partner firms design solutions for their clients,” Chairman Dr. Vinay Nair said. “We are also thrilled that our research team will have access to his guidance.”

“I am honoured to move from research partner to Chief Investment Scientist and help Vinay, Paul and the team realize their mission to arm clients with the best technology and the best brain trust available,” Dr. Kogan said.

“Because we are adept in both tech development and investment science and can move nimbly and quickly, we are in a great position to stay on top of marketplace trends and deliver real solutions.”